White House Endorses Finance Rx Pricing Bill, PhRMA Opposes It

By Rachel Cohrs / July 23, 2019 at 6:01 PM
The White House expressed support on Tuesday (July 23) for the Senate Finance Committee’s new drug-pricing bill as did the generic drug lobby, but the brand-drug lobby came out against it. The White House supports the Finance bill and is working to promote it, spokesman Judd Deere said. “We will work with Senators to ensure this proposal moves forward and advances the President’s priority of lowering drug prices even further and increasing transparency in healthcare for the benefit of all...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.